BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
7/15/2025 8:26:21 AM | Browse: 4 | Download: 17
Publication Name World Journal of Diabetes
Manuscript ID 105219
Country China
Received
2025-01-15 12:14
Peer-Review Started
2025-01-17 01:06
To Make the First Decision
Return for Revision
2025-03-21 06:51
Revised
2025-04-02 16:51
Second Decision
2025-05-23 00:45
Accepted by Journal Editor-in-Chief
2025-05-27 14:51
Accepted by Executive Editor-in-Chief
2025-05-28 06:46
Articles in Press
2025-05-28 06:46
Publication Fee Transferred
2025-04-03 14:29
Edit the Manuscript by Language Editor
Typeset the Manuscript
2025-07-03 07:49
Publish the Manuscript Online
2025-07-15 08:26
ISSN 1948-9358 (online)
Open Access This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: https://creativecommons.org/Licenses/by-nc/4.0/
Copyright © The Author(s) 2024. Published by Baishideng Publishing Group Inc. All rights reserved.
Article Reprints For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
Permissions For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
Publisher Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
Website http://www.wjgnet.com
Category Health Care Sciences & Services
Manuscript Type Clinical Trials Study
Article Title Efficacy of Xiaokeqing granules and lifestyle intervention in treating prediabetes mellitus considering metabolomic biomarkers: A randomised controlled trial
Manuscript Source Unsolicited Manuscript
All Author List Jin-Dong Zhao, Meng-Zhu Guo, Yi Zhang, Shao-Hua Zhu, Ya-Ting Wang, Yan-Ping Zhang, Xin Liu, Si Cheng, Fei Wang, Qi Xu, Nuo-Bing Ruan and Zhao-Hui Fang
ORCID
Author(s) ORCID Number
Jin-Dong Zhao http://orcid.org/0000-0003-0005-1820
Zhao-Hui Fang http://orcid.org/0000-0002-3197-1534
Funding Agency and Grant Number
Funding Agency Grant Number
Open Bidding for Selecting the Best Candidates for Xin’an Medicine and the Modernization of Traditional Chinese Medicine of IHM No. 2023CXMMTCM024
Open Bidding for Selecting the Best Candidates for Xin’an Medicine and the Modernization of Traditional Chinese Medicine of IHM No. 2023CXMMTCM003
Anhui University Collaborative Innovation Project No. GXXT-2020-025
Scientific Research Project of Health and Wellness in Anhui Province No. AHWJ2023BAc10002
Anhui Province New Era Education Quality Project No. 2023 gjxslt014
Clinical and Translational Research Project of Anhui Province No. 202427b10020046
Corresponding Author Zhao-Hui Fang, Department of Endocrinology, The First Affiliated Hospital of Anhui University of Chinese Medicine, No. 117 Meishan Road, Hefei 230031, Anhui Province, China. fangzhaohui1111@163.com
Key Words Prediabetes mellitus; Xiaokeqing granules; Lifestyle; Two-hour postprandial glucose; Metabolomics; Tryptophan metabolism
Core Tip In this study, Xiaokeqing granules constitute a new class-three traditional Chinese medicine. They can improve 2-hour postprandial glucose in participants with prediabetes mellitus with yin deficiency syndrome with excessive heat according to a preliminary investigation and an exploratory randomised controlled trial. Groenlandicine and kaempferol are the main Xiaokeqing granule constituents absorbed into the blood. N-Nervonoyl methionine and 5-hydroxy-L-tryptophan are potential biomarkers for the effectiveness of Xiaokeqing granules and lifestyle interventions.
Publish Date 2025-07-15 08:26
Citation <p>Zhao JD, Guo MZ, Zhang Y, Zhu SH, Wang YT, Zhang YP, Liu X, Cheng S, Wang F, Xu Q, Ruan NB, Fang ZH. Efficacy of Xiaokeqing granules and lifestyle intervention in treating prediabetes mellitus considering metabolomic biomarkers: A randomised controlled trial. <i>World J Diabetes</i> 2025; 16(7): 105219</p>
URL https://www.wjgnet.com/1948-9358/full/v16/i7/105219.htm
DOI https://dx.doi.org/10.4239/wjd.v16.i7.105219
Full Article (PDF) WJD-16-105219-with-cover.pdf
CONSORT 2010 Statement 105219-CONSORT-2010-statement.pdf
Manuscript File 105219_Auto_Edited_015239.docx
Answering Reviewers 105219-answering-reviewers.pdf
Audio Core Tip 105219-audio.wav
Biostatistics Review Certificate 105219-biostatistics-statement.pdf
Clinical Trial Registration Statement 105219-clinical-trial-registration-statement.pdf
Conflict-of-Interest Disclosure Form 105219-conflict-of-interest-statement.pdf
Copyright License Agreement 105219-copyright-assignment.pdf
Approved Grant Application Form(s) or Funding Agency Copy of any Approval Document(s) 105219-foundation-statement.pdf
Signed Informed Consent Form(s) or Document(s) 105219-informed-consent-statement.pdf
Institutional Review Board Approval Form or Document 105219-institutional-review-board-statement.pdf
Non-Native Speakers of English Editing Certificate 105219-non-native-speakers.pdf
Peer-review Report 105219-peer-reviews.pdf
Journal Editor-in-Chief Review Report 105219-journal-editor-in-chief.pdf
Scientific Misconduct Check 105219-scientific-misconduct-check.png
Scientific Editor Work List 105219-scientific-editor-work-list.pdf
CrossCheck Report 105219-crosscheck-report.pdf